688799.SH
Hunan Warrant Pharmaceutical Co., Ltd.
SSE · Healthcare · Drug Manufacturers - Specialty & Generic · CN
CNY 43.33
−0.73%Price chart
Aug 20Aug 25Aug 28Sep 2Sep 7Sep 10Sep 15Sep 18
Key dataSep 18, 2026
OpenCNY 53.00
From 52W high−25.72%
Volume4.75M
Market capCNY 5.79B
P/E (TTM)24.3x
P/S (TTM)5.0x
Div yield0.32%
Key dataSep 18, 2026
Open
CNY 53.00
From 52W high
−25.72%
Volume
4.75M
Market cap
CNY 5.79B
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
—
P/E (TTM)
24.3x
RSI (14)
70.6
MomentumView details →
1D Return
−0.73%
YTD Return
—
Similar companies
Latest newsMore news →
Hunan Huana Pharmaceutical Investment Partnership (Limited Partnership), controlling shareholder of Huana Pharmaceutical, sold 1.38 million shares via block trade on September 17, 2026, reducing its and concert parties' combined stake from 39.09% to 38.06%.3d agoWarner Pharmaceutical received a drug registration certificate approved by the National Medical Products Administration for Loxoprofen Sodium Patch, used for anti-inflammatory and analgesic purposes, available in two specifications.20d ago